Issue Navigation
-
Review
-
109-116
Marouf BH, Dizaye K
Drug Discov Ther. 2020; 14(3):109-116.
DOI: 10.5582/ddt.2020.03035
-
117-121
Ohashi H, Takeuchi S, Miyagaki T, Kadono T
Drug Discov Ther. 2020; 14(3):117-121.
DOI: 10.5582/ddt.2020.03043
-
122-128
Mallone F, Lucchino L, Franzone F, Marenco M, Carlesimo SC, Moramarco A
Drug Discov Ther. 2020; 14(3):122-128.
DOI: 10.5582/ddt.2020.03031
-
129-134
Nannoni G, Volterrani G, Mattarocci A, Minoretti P, Emanuele E
Drug Discov Ther. 2020; 14(3):129-134.
DOI: 10.5582/ddt.2020.03034
-
135-138
Ali N, Gupta N, Saravu K
Drug Discov Ther. 2020; 14(3):135-138.
DOI: 10.5582/ddt.2020.03029
-
139-142
Can mesenchymal stem cell therapy be the interim management of COVID-19?
Bamba C, Singh SP, Choudhury S
Drug Discov Ther. 2020; 14(3):139-142.
DOI: 10.5582/ddt.2020.03032
-
143-144
Kazama I
Drug Discov Ther. 2020; 14(3):143-144.
DOI: 10.5582/ddt.2020.03046
-
145-148
Chen MX, Cong LX, He JJ, Yang Y, Xu Y, Tang M, Jin CL
Drug Discov Ther. 2020; 14(3):145-148.
DOI: 10.5582/ddt.2020.03024
-
149-150
Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research
Wang JJ, Qi FH
Drug Discov Ther. 2020; 14(3):149-150.
DOI: 10.5582/ddt.2020.03054
-
151-152
Devoting attention to the management of community-acquired pneumonia for the elderly
Song PP
Drug Discov Ther. 2020; 14(3):151-152.
DOI: 10.5582/ddt.2020.03055